Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Celgene and Forma enter second collaboration; Celgene gets buy-out option

Executive Summary

Celgene Corp. and drug discovery firm Forma Therapeutics Holdings LLC entered into their second partnership in just a year, this time teaming up for the discovery and development of compounds spanning a variety of therapeutic areas including cancer, with the potential for Celgene to buy Forma outright at the end of a possible seven-and-a-half year term.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • R+D and Marketing-Licensing
    • Includes M&A Option

Related Companies

Advertisement
UsernamePublicRestriction

Register